Linked Data API

Show Search Form

Search Results

1716843
registered interest true more like this
date less than 2024-05-09more like thismore than 2024-05-09
answering body
Speaker's Committee on the Electoral Commission more like this
answering dept id 36 more like this
answering dept short name Speaker's Committee on the Electoral Commission more like this
answering dept sort name Speaker's Committee on the Electoral Commission more like this
hansard heading Political Parties: Registration more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the hon. Member for Lancaster and Fleetwood, representing the Speaker's Committee on the Electoral Commission, if she will hold discussions with the Electoral Commission on the reasons for which it rejected the application from (a) Kingston Independent Residents Group and (b) Workers Party Britain on registering a description that included the leaders of those parties. more like this
tabling member constituency Rochdale more like this
tabling member printed
George Galloway more like this
uin 25444 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>Parties have the option to register descriptions which can appear on the ballot paper, instead of the party name. As the registrar for political parties, electoral law requires the Commission to assess whether a party’s description meets the requirements set out in law. If it does not, the description cannot be registered.</p><p>If a person, other than the candidate, is named in a description and thus appeared on the ballot paper, it is likely to mislead a voter about the candidate standing in their area. It would not therefore meet the legal requirements for a description, and the Commission would be required to refuse it.</p> more like this
answering member constituency Lancaster and Fleetwood more like this
answering member printed Cat Smith more like this
question first answered
less than 2024-05-13T09:41:23.637Zmore like thismore than 2024-05-13T09:41:23.637Z
answering member
4436
label Biography information for Cat Smith more like this
tabling member
609
label Biography information for George Galloway more like this
1716362
registered interest false more like this
date less than 2024-05-08more like thismore than 2024-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Lung Cancer: Artificial Intelligence more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 May 2024 to Question 24269 on Lung Cancer: Artificial Intelligence, which (a) NHS trusts have and (b) imaging network has not received funding. more like this
tabling member constituency Hove more like this
tabling member printed
Peter Kyle more like this
uin 25291 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>Since the initial announcements regarding funding for National Health Service trusts to integrate artificial intelligence into lung cancer imaging, adjustments have been made to the list of participants. Three trusts have withdrawn from the initiative, and five additional trusts have been onboarded, due to the inclusion of a new imaging network. As a result, as set out in the answer of 7 May 2024, there are now 66 trusts across 12 imaging networks that are participating in this initiative.</p><p>In the answer of 7 May 2024, 63 out of 66 trusts, in 11 of 12 imaging networks, had received funding. It is now confirmed that all 66 trusts in the 12 imaging networks participating have received or are in the process of receiving funding. These trusts are currently implementing artificial intelligence technologies to enhance diagnostic capabilities in lung cancer, consistent with the Government's commitment to advancing healthcare technology across the NHS.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-13T08:24:50.047Zmore like thismore than 2024-05-13T08:24:50.047Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4505
label Biography information for Peter Kyle more like this
1716421
registered interest false more like this
date less than 2024-05-08more like thismore than 2024-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what discussions she (a) has had and (b) plans to have with (i) charities and (ii) other organisations working to secure UK access to new drugs for (A) incurable, (B) relapsing and (C) remitting cancers such as myeloma. more like this
tabling member constituency Birmingham, Yardley more like this
tabling member printed
Jess Phillips more like this
uin 25238 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>Department ministers and officials regularly meet with a range of organisations, with an interest in securing patient access to new cancer medicines. The National Institute for Health and Care Excellence (NICE) is the body that develops authoritative, evidence-based guidance for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits, including medicines for myeloma. The NICE aims to publish guidance on all new medicines close to the point of licensing wherever possible, and has recommended many cancer medicines for NHS use that are now available to NHS patients, including through the Cancer Drugs Fund.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-13T08:43:01.5Zmore like thismore than 2024-05-13T08:43:01.5Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4370
label Biography information for Jess Phillips more like this
1716422
registered interest false more like this
date less than 2024-05-08more like thismore than 2024-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether she (a) has had discussions and (b) plans to have discussions with the National Institute for Health and Care Excellence on (i) its use of the new severity modifier and (ii) how it (A) measures and (B) reports the impact of the modifier on approval of treatments for (1) cancers, (2) relapsing and remitting conditions and (3) conditions that are more prevalent in older people. more like this
tabling member constituency Birmingham, Yardley more like this
tabling member printed
Jess Phillips more like this
uin 25239 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>The Department regularly meets with colleagues in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including in relation to the NICE’s methods for the evaluation of medicines. In 2022, the NICE introduced a number of changes to make its methods and processes fairer, faster, and more consistent. This includes the introduction of a broader severity modifier, in place of the end-of-life modifier. Since the changes were introduced, 79% of the NICE’s appraisals of cancer medicines carried out under the updated methods have recommended the use of the treatment for some or all of the eligible patient population, either for routine use or use through the Cancer Drugs Fund. The approval rate for all cancer appraisals carried out since 2009, when the end-of-life modifier was introduced, is 78%.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-13T08:48:27.183Zmore like thismore than 2024-05-13T08:48:27.183Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4370
label Biography information for Jess Phillips more like this
1716532
registered interest false more like this
date less than 2024-05-08more like thismore than 2024-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Joint Replacements: Surgery more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many and what proportion of people received treatment for (a) knee and (b) hip replacements in surgical hubs in each of the last 12 months. more like this
tabling member constituency York Central more like this
tabling member printed
Rachael Maskell more like this
uin 25261 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>NHS England has introduced specific hub-level data site codes for all operational hubs in 2023, with 89% of the 101 operational hubs now reporting data against these codes. However, as many of the hubs have only recently introduced the data codes, NHS England have limited data available for the last 12 months, and much of this new data submission is still being validated. Therefore, NHS England currently do not have reliable, validated hub-specific data about specific procedures undertaken in hubs.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-13T08:52:57.627Zmore like thismore than 2024-05-13T08:52:57.627Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4471
label Biography information for Rachael Maskell more like this
1716566
registered interest false more like this
date less than 2024-05-08more like thismore than 2024-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liver Diseases: Shropshire more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure there are effective pathways for early detection of liver disease in Shropshire. more like this
tabling member constituency North Shropshire more like this
tabling member printed
Helen Morgan more like this
uin 25400 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>Early detection of liver disease is vital to enable interventions, and encourage behavioural changes that can potentially lead to recovery. Liver disease is one of the primary risk factors for liver cancer. Across the Shropshire, Telford, and Wrekin Integrated Care Board (ICB) area, the early detection of liver disease is led by primary care partners, and the ICB encourages general practitioners to follow best practice in the delivery of patient care pathways, to ensure the early detection of liver disease in patients. The Shrewsbury and Telford Hospital NHS Trust is working with primary care partners to increase awareness and provide tools to support this work. The hospital also carries out active outreach into the community for drug and alcohol patients.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-13T08:39:47.007Zmore like thismore than 2024-05-13T08:39:47.007Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4934
label Biography information for Helen Morgan more like this
1715989
registered interest false more like this
date less than 2024-05-07more like thismore than 2024-05-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Injuries: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if she will make an estimate of when single-step scaffold insertion will be available on the NHS for people with torn cartilage injuries. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon more like this
uin 24913 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-10more like thismore than 2024-05-10
answer text <p>The National Institute for Health and Care Excellence (NICE) is currently consulting on draft interventional procedures guidance that recommends single-step scaffold insertion as an option for repairing symptomatic chondral knee defects, with standard arrangements in place for clinical governance, consent, and audit. The NICE currently expects to publish final guidance in September 2024. Once the NICE has published final guidance, National Health Service organisations will be expected to take it fully into account, but the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-10T13:49:44.2Zmore like thismore than 2024-05-10T13:49:44.2Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1715998
registered interest false more like this
date less than 2024-05-07more like thismore than 2024-05-07
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading Bail: Remote Hearings more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, what discussions he has had with the Courts and Tribunals Judiciary on its decision to make second and subsequent bail applications remote by default. more like this
tabling member constituency Stockton North more like this
tabling member printed
Alex Cunningham more like this
uin 24910 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>It is standard practice not to comment on discussions between Ministers and the judiciary.</p><p>The Lord Chancellor is supportive of any efforts to help ensure sufficient capacity in the courts to hear bail applications and to remove principal structural barriers to applications being submitted, and he welcomes the revised guidance launched by Judicial Office which sets out that all second and subsequent bail applications to the Crown Court should be heard remotely unless ordered otherwise by a judge.</p> more like this
answering member constituency Charnwood more like this
answering member printed Edward Argar more like this
question first answered
less than 2024-05-13T08:49:11.387Zmore like thismore than 2024-05-13T08:49:11.387Z
answering member
4362
label Biography information for Edward Argar more like this
tabling member
4122
label Biography information for Alex Cunningham more like this
1715999
registered interest false more like this
date less than 2024-05-07more like thismore than 2024-05-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Leukaemia: Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps she is taking to improve research into acute myeloid leukaemia. more like this
tabling member constituency Lancaster and Fleetwood more like this
tabling member printed
Cat Smith more like this
uin 24951 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-09more like thismore than 2024-05-09
answer text <p>The Department is proud to invest £1.3 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was over £121.8 million for 2022/23, and more is spent on cancer than any other disease group.</p><p> </p><p>The Government, through the NIHR, is committed to improving research into the cancers with the poorest survival rates, such as acute myeloid leukaemia, by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer, and other less survivable cancers. The following table shows NIHR research spend on diagnosis, treatment, and diagnosis and treatment of blood cancers, which includes leukaemia, since 2018:<br></p><table><tbody><tr><td><p>Number of projects</p></td><td><p>Total awards value</p></td></tr><tr><td><p>Blood cancer diagnosis</p></td><td><p>11</p></td><td><p>£11,900,000</p></td></tr><tr><td><p>Blood cancer treatment</p></td><td><p>14</p></td><td><p>£14,700,000</p></td></tr><tr><td><p>Blood cancer diagnosis and treatment</p></td><td><p>4</p></td><td><p>£7,700,000</p></td></tr></tbody></table><p><br> In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council’s two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.</p><p><br> The NIHR continues to encourage and welcome applications for research into any aspect of human health, including acute myeloid leukaemia. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals, and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers, made through open competition, have been funded.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-05-09T13:32:26.063Zmore like thismore than 2024-05-09T13:32:26.063Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4436
label Biography information for Cat Smith more like this
1716054
registered interest false more like this
date less than 2024-05-07more like thismore than 2024-05-07
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading Ministry of Justice: ICT more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, with reference to the guidance by the Central Digital and Data Office entitled Guidance on the Legacy IT Risk Assessment Framework, published on 29 September 2023, how many red-rated IT systems are used by his Department; and how many red-rated IT systems have been identified since 4 December 2023. more like this
tabling member constituency Reading East more like this
tabling member printed
Matt Rodda more like this
uin 25013 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-13more like thismore than 2024-05-13
answer text <p>The Central Digital and Data Office (CDDO), in the Cabinet Office, has established a programme to support departments managing legacy IT. CDDO has agreed a framework to identify ‘red-rated’ systems, indicating high levels of risk surrounding certain assets within the IT estate. Departments have committed to have remediation plans in place for these systems by next year (2025).</p><p>It is not appropriate to release sensitive information held about specific red-rated systems or more detailed plans for remediation within the Ministry of Justice’s IT estate, as this information could indicate which systems are at risk, and may highlight potential security vulnerabilities.</p> more like this
answering member constituency Finchley and Golders Green more like this
answering member printed Mike Freer more like this
question first answered
less than 2024-05-13T09:12:33.457Zmore like thismore than 2024-05-13T09:12:33.457Z
answering member
4004
label Biography information for Mike Freer more like this
tabling member
4654
label Biography information for Matt Rodda more like this